EP4431180A2 - Olefinmetathesekatalysatoren - Google Patents

Olefinmetathesekatalysatoren Download PDF

Info

Publication number
EP4431180A2
EP4431180A2 EP24186768.8A EP24186768A EP4431180A2 EP 4431180 A2 EP4431180 A2 EP 4431180A2 EP 24186768 A EP24186768 A EP 24186768A EP 4431180 A2 EP4431180 A2 EP 4431180A2
Authority
EP
European Patent Office
Prior art keywords
optionally substituted
alkyl
aryl
hydrogen
cycloalkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24186768.8A
Other languages
English (en)
French (fr)
Other versions
EP4431180A3 (de
Inventor
Adam JOHNS
Patric T. Montgomery
Tonia S. Ahmed
Robert H. Grubbs
Richard L. Pederson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Umicore AG and Co KG
California Institute of Technology
Original Assignee
Umicore AG and Co KG
California Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Umicore AG and Co KG, California Institute of Technology filed Critical Umicore AG and Co KG
Publication of EP4431180A2 publication Critical patent/EP4431180A2/de
Publication of EP4431180A3 publication Critical patent/EP4431180A3/de
Pending legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2265Carbenes or carbynes, i.e.(image)
    • B01J31/2278Complexes comprising two carbene ligands differing from each other, e.g. Grubbs second generation catalysts
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2204Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/226Sulfur, e.g. thiocarbamates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2265Carbenes or carbynes, i.e.(image)
    • B01J31/2269Heterocyclic carbenes
    • B01J31/2273Heterocyclic carbenes with only nitrogen as heteroatomic ring members, e.g. 1,3-diarylimidazoline-2-ylidenes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2282Unsaturated compounds used as ligands
    • B01J31/2295Cyclic compounds, e.g. cyclopentadienyls
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C6/00Preparation of hydrocarbons from hydrocarbons containing a different number of carbon atoms by redistribution reactions
    • C07C6/02Metathesis reactions at an unsaturated carbon-to-carbon bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C6/00Preparation of hydrocarbons from hydrocarbons containing a different number of carbon atoms by redistribution reactions
    • C07C6/02Metathesis reactions at an unsaturated carbon-to-carbon bond
    • C07C6/04Metathesis reactions at an unsaturated carbon-to-carbon bond at a carbon-to-carbon double bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C6/00Preparation of hydrocarbons from hydrocarbons containing a different number of carbon atoms by redistribution reactions
    • C07C6/02Metathesis reactions at an unsaturated carbon-to-carbon bond
    • C07C6/04Metathesis reactions at an unsaturated carbon-to-carbon bond at a carbon-to-carbon double bond
    • C07C6/06Metathesis reactions at an unsaturated carbon-to-carbon bond at a carbon-to-carbon double bond at a cyclic carbon-to-carbon double bond
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/50Redistribution or isomerisation reactions of C-C, C=C or C-C triple bonds
    • B01J2231/54Metathesis reactions, e.g. olefin metathesis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/50Redistribution or isomerisation reactions of C-C, C=C or C-C triple bonds
    • B01J2231/54Metathesis reactions, e.g. olefin metathesis
    • B01J2231/543Metathesis reactions, e.g. olefin metathesis alkene metathesis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82Metals of the platinum group
    • B01J2531/821Ruthenium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2531/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • C07C2531/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • C07C2531/22Organic complexes

Definitions

  • This invention relates generally to metathesis catalysts and the use of such catalysts in the metathesis of olefins and olefin compounds, more particularly, in the use of such catalysts in Z or E selective olefin metathesis reactions, particularly Z or E selective cross metathesis reactions.
  • the invention has utility in the fields of organometallics and organic synthesis.
  • transition-metal catalyzed olefin metathesis reaction is an important methodology for the construction of new carbon-carbon double bonds (see (a) Fürstner, A. Angew. Chem., Int. Ed. 2000, 39, 3013 . (b) Trnka, T. M.; Grubbs, R. H. Acc. Chem. Res. 2001, 34, 18 . (c) Schrock, R. R. Chem. Rev. 2002, 102, 145 . (d) Schrock, R. R.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2003, 42, 4592 . (e) Vougioukalakis, G.; Grubbs, R. H. Chem. Rev. 2009, 110, 1746 . (f) Samoj owicz, C.; Bieniek, M.; Grela, K. Chem. Rev. 2009, 109, 3708).
  • CM cross metathesis
  • the invention provides a compound of Formula (I): wherein:
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second internal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant and the second internal olefin reactant may be the same or different, where the first internal olefin reactant and the second internal olefin reactant are each in a Z -configuration; and where the at least one cross metathesis product is greater than about 80% Z .
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second internal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant and the second internal olefin reactant may be the same or different, where the first internal olefin reactant and the second internal olefin reactant are each in a Z -configuration; and where the at least one cross metathesis product is greater than about 90% Z .
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second internal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant and the second internal olefin reactant may be the same or different, where the first internal olefin reactant and the second internal olefin reactant are each in a Z -configuration; and where the at least one cross metathesis product is greater than about 95% Z .
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second internal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant and the second internal olefin reactant may be the same or different, where the first internal olefin reactant and the second internal olefin reactant are each in a Z -configuration; and where the at least one cross metathesis product is greater than about 99% Z .
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second internal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant and the second internal olefin reactant may be the same or different, where the first internal olefin reactant and the second internal olefin reactant are each in an E -configuration; and where the at least one cross metathesis product is greater than about 80% E .
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second internal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant and the second internal olefin reactant may be the same or different, where the first internal olefin reactant and the second internal olefin reactant are each in an E -configuration; and where the at least one cross metathesis product is greater than about 90% E.
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second internal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant and the second internal olefin reactant may be the same or different, where the first internal olefin reactant and the second internal olefin reactant are each in an E -configuration; and where the at least one cross metathesis product is greater than about 95% E .
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second internal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant and the second internal olefin reactant may be the same or different, where the first internal olefin reactant and the second internal olefin reactant are each in an E -configuration; and where the at least one cross metathesis product is greater than about 99% E .
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second terminal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant is in a Z -configuration; and where the at least one cross metathesis product is greater than about 80% Z .
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second terminal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant is in a Z -configuration; and where the at least one cross metathesis product is greater than about 90% Z .
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second terminal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant is in a Z -configuration; and where the at least one cross metathesis product is greater than about 95% Z .
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second terminal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant is in a Z -configuration; and where the at least one cross metathesis product is greater than about 99% Z .
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second terminal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant is in an E -configuration; and where the at least one cross metathesis product is greater than about 80% E .
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second terminal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant is in an E -configuration; and where the at least one cross metathesis product is greater than about 90% E .
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second terminal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant is in an E -configuration; and where the at least one cross metathesis product is greater than about 95% E .
  • the invention provides a method for performing a cross metathesis reaction, comprising: contacting a first internal olefin reactant with a second terminal olefin reactant in the presence of a compound of Formula (I), under conditions effective to promote the formation of at least one cross metathesis product, where the first internal olefin reactant is in an E -configuration; and where the at least one cross metathesis product is greater than about 99% E .
  • the invention provides for use of a compound of Formula (I) in olefin metathesis. In one embodiment, the invention provides for use of a compound of Formula (I) in an olefin metathesis reaction. In one embodiment, the invention provides for use of a compound of Formula (I) in a Z -selective olefin metathesis reaction. In one embodiment, the invention provides for use of a compound of Formula (I) in a Z -selective cross metathesis reaction.
  • the invention provides for use of a compound of Formula (I) in olefin metathesis. In one embodiment, the invention provides for use of a compound of Formula (I) in an olefin metathesis reaction. In one embodiment, the invention provides for use of a compound of Formula (I) in an E -selective olefin metathesis reaction. In one embodiment, the invention provides for use of a compound of Formula (I) in an E -selective cross metathesis reaction.
  • the invention provides a method for performing a Z -selective olefin metathesis reaction. In one embodiment, the invention provides a method for performing a Z -selective cross metathesis reaction.
  • the invention provides a method for performing an E- selective olefin metathesis reaction. In one embodiment, the invention provides a method for performing an E -selective cross metathesis reaction.
  • an ⁇ -olefin includes a single ⁇ -olefin as well as a combination or mixture of two or more ⁇ -olefins
  • reference to "a substituent” encompasses a single substituent as well as two or more substituents, and the like.
  • alkyl refers to a linear, branched, or cyclic saturated hydrocarbon group typically although not necessarily containing 1 to about 24 carbon atoms, preferably 1 to about 12 carbon atoms, such as methyl (Me), ethyl (Et), n-propyl (Pr or n-Pr), isopropyl (i-Pr), n-butyl (Bu or n-Bu), isobutyl (i-Bu), t-butyl (t-Bu), octyl (Oct), decyl, and the like, as well as cycloalkyl groups such as cyclopentyl (Cp), cyclohexyl (Cy) and the like.
  • alkyl groups herein contain 1 to about 8 carbon atoms.
  • the term “lower alkyl” refers to an alkyl group of 1 to 6 carbon atoms
  • the specific term “cycloalkyl” refers to a cyclic alkyl group, typically having 3 to 8, preferably 5 to 7, carbon atoms.
  • substituted alkyl refers to alkyl substituted with one or more substituent groups
  • heteroatom-containing alkyl and “heteroalkyl” refer to alkyl in which at least one carbon atom is replaced with a heteroatom. If not otherwise indicated, the terms “alkyl” and “lower alkyl” include linear, branched, cyclic, unsubstituted, substituted, and/or heteroatom-containing alkyl and lower alkyl, respectively.
  • alkylene refers to a difunctional linear, branched, or cyclic alkyl group, where "alkyl” is as defined above.
  • alkenyl refers to a linear, branched, or cyclic hydrocarbon group of 2 to about 24 carbon atoms containing at least one double bond, such as ethenyl, n-propenyl, isopropenyl, n-butenyl, isobutenyl, octenyl, decenyl, tetradecenyl, hexadecenyl, eicosenyl, tetracosenyl, and the like.
  • Preferred alkenyl groups herein contain 2 to about 12 carbon atoms.
  • lower alkenyl refers to an alkenyl group of 2 to 6 carbon atoms
  • cycloalkenyl refers to a cyclic alkenyl group, preferably having 3 to 8 carbon atoms.
  • substituted alkenyl refers to alkenyl substituted with one or more substituent groups
  • heteroatom-containing alkenyl and “heteroalkenyl” refer to alkenyl in which at least one carbon atom is replaced with a heteroatom. If not otherwise indicated, the terms “alkenyl” and “lower alkenyl” include linear, branched, cyclic, unsubstituted, substituted, and/or heteroatom-containing alkenyl and lower alkenyl, respectively.
  • alkenylene refers to a difunctional linear, branched, or cyclic alkenyl group, where "alkenyl” is as defined above.
  • alkynyl refers to a linear or branched hydrocarbon group of 2 to about 24 carbon atoms containing at least one triple bond, such as ethynyl, n-propynyl, and the like. Preferred alkynyl groups herein contain 2 to about 12 carbon atoms. The term “lower alkynyl” refers to an alkynyl group of 2 to 6 carbon atoms.
  • substituted alkynyl refers to alkynyl substituted with one or more substituent groups
  • heteroatom-containing alkynyl and “heteroalkynyl” refer to alkynyl in which at least one carbon atom is replaced with a heteroatom.
  • alkynyl and “lower alkynyl” include linear, branched, unsubstituted, substituted, and/or heteroatom-containing alkynyl and lower alkynyl, respectively.
  • alkynylene refers to a difunctional alkynyl group, where "alkynyl” is as defined above.
  • alkoxy refers to an alkyl group bound through a single, terminal ether linkage; that is, an "alkoxy” group may be represented as -O-alkyl where alkyl is as defined above.
  • a “lower alkoxy” group refers to an alkoxy group containing 1 to 6 carbon atoms.
  • alkenyloxy and lower alkenyloxy respectively refer to an alkenyl and lower alkenyl group bound through a single, terminal ether linkage
  • alkynyloxy and “lower alkynyloxy” respectively refer to an alkynyl and lower alkynyl group bound through a single, terminal ether linkage.
  • aryl refers to an aromatic substituent containing a single aromatic ring or multiple aromatic rings that are fused together, directly linked, or indirectly linked (such that the different aromatic rings are bound to a common group such as a methylene or ethylene moiety).
  • Preferred aryl groups contain 5 to 24 carbon atoms, and particularly preferred aryl groups contain 6 to 10 carbon atoms.
  • Exemplary aryl groups contain one aromatic ring or two fused or linked aromatic rings, e.g., phenyl (Ph), naphthyl, biphenyl, diphenylether, diphenylamine, benzophenone, phenanthryl and the like.
  • Substituted aryl refers to an aryl moiety substituted with one or more substituent groups
  • heteroatom containing aryl and “heteroaryl” refer to aryl substituents in which at least one carbon atom is replaced with a heteroatom, as will be described in further detail herein.
  • aryloxy refers to an aryl group bound through a single, terminal ether linkage, wherein "aryl” is as defined above.
  • An "aryloxy” group may be represented as -O-aryl where aryl is as defined above.
  • Preferred aryloxy groups contain 5 to 24 carbon atoms, and particularly preferred aryloxy groups contain 6 to 10 carbon atoms.
  • aryloxy groups include, without limitation, phenoxy, o-halo-phenoxy, m-halo-phenoxy, p-halo-phenoxy, o-methoxy-phenoxy, m-methoxy-phenoxy, p-methoxy-phenoxy, 2,4-dimethoxy-phenoxy, 3,4,5-trimethoxy-phenoxy, and the like.
  • alkaryl refers to an aryl group with an alkyl substituent
  • aralkyl refers to an alkyl group with an aryl substituent, wherein “aryl” and “alkyl” are as defined above.
  • Preferred alkaryl and aralkyl groups contain 6 to 24 carbon atoms, and particularly preferred alkaryl and aralkyl groups contain 6 to 16 carbon atoms.
  • Alkaryl groups include, without limitation, p-methylphenyl, 2,4-dimethylphenyl, p-cyclohexylphenyl, 2,7-dimethylnaphthyl, 7-cyclooctylnaphthyl, 3-ethyl-cyclopenta-1,4-diene, and the like.
  • aralkyl groups include, without limitation, benzyl, 2-phenyl-ethyl, 3-phenyl-propyl, 4-phenylbutyl, 5-phenyl-pentyl, 4-phenylcyclohexyl, 4-benzylcyclohexyl, 4-phenylcyclohexylmethyl, 4-benzylcyclohexylmethyl, and the like.
  • alkaryloxy and aralkyloxy refer to substituents of the formula -OR wherein R is alkaryl or aralkyl, respectively, as just defined.
  • acyl refers to substituents having the formula -(CO)-alkyl, -(CO)-aryl, - (CO)-aralkyl, -(CO)-alkaryl, -(CO)-alkenyl, or -(CO)-alkynyl
  • acyloxy refers to substituents having the formula -O(CO)-alkyl, -O(CO)-aryl, -O(CO)-aralkyl, -O(CO)-alkaryl, - O(CO)-alkenyl, or -(CO)-alkynyl wherein "alkyl,” “aryl”, “aralkyl”, “alkaryl”, “alkenyl", and “alkynyl” are as defined above.
  • the acetoxy group (-O(CO)CH 3 ; often abbreviated as -OAc) is a common example of an acyloxy group.
  • cyclic and ring refer to alicyclic or aromatic groups that may or may not be substituted and/or heteroatom containing, and that may be monocyclic, bicyclic, or polycyclic.
  • alicyclic is used in the conventional sense to refer to an aliphatic cyclic moiety, as opposed to an aromatic cyclic moiety, and may be monocyclic, bicyclic or polycyclic.
  • polycyclic ring refer to alicyclic or aromatic groups that may or may not be substituted and/or heteroatom containing, and that have at least two closed rings tethered, fused, linked via a single bond or bridged.
  • Polycyclic rings include without limitation naphthyl, biphenyl, phenanthryl and the like.
  • halo and “halogen” and “halide” are used in the conventional sense to refer to a fluoro, chloro, bromo, or iodo substituent.
  • Hydrocarbyl refers to univalent hydrocarbyl radicals containing 1 to about 30 carbon atoms, preferably 1 to about 24 carbon atoms, most preferably 1 to about 12 carbon atoms, including linear, branched, cyclic, saturated and unsaturated species, such as alkyl groups, alkenyl groups, alkynyl groups, aryl groups, and the like.
  • lower hydrocarbyl refers to a hydrocarbyl group of 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms
  • hydrocarbylene refers to a divalent hydrocarbyl moiety containing 1 to about 30 carbon atoms, preferably 1 to about 24 carbon atoms, most preferably 1 to about 12 carbon atoms, including linear, branched, cyclic, saturated and unsaturated species.
  • lower hydrocarbylene refers to a hydrocarbylene group of 1 to 6 carbon atoms.
  • Substituted hydrocarbyl refers to hydrocarbyl substituted with one or more substituent groups
  • heteroatom-containing hydrocarbyl and “heterohydrocarbyl” refer to hydrocarbyl in which at least one carbon atom is replaced with a heteroatom
  • substituted hydrocarbylene refers to hydrocarbylene substituted with one or more substituent groups
  • heteroatom-containing hydrocarbylene and heterohydrocarbylene refer to hydrocarbylene in which at least one carbon atom is replaced with a heteroatom.
  • hydrocarbyl and hydrocarbylene are to be interpreted as including substituted and/or heteroatom-containing hydrocarbyl and hydrocarbylene moieties, respectively.
  • heteroatom-containing refers to a hydrocarbon molecule or a hydrocarbyl molecular fragment in which one or more carbon atoms is replaced with an atom other than carbon, e.g., nitrogen, oxygen, sulfur, phosphorus or silicon, typically nitrogen, oxygen or sulfur.
  • heteroalkyl refers to an alkyl substituent that is heteroatom-containing
  • heterocyclic refers to a cyclic substituent that is heteroatom-containing
  • heteroaryl and “heteroaromatic” respectively refer to "aryl” and "aromatic” substituents that are heteroatom-containing, and the like.
  • heterocyclic group or compound may or may not be aromatic, and further that “heterocycles” may be monocyclic, bicyclic, or polycyclic as described above with respect to the term "aryl.”
  • heteroalkyl groups include without limitation alkoxyaryl, alkylsulfanyl-substituted alkyl, N-alkylated amino alkyl, and the like.
  • heteroaryl substituents include without limitation pyrrolyl, pyrrolidinyl, pyridinyl, quinolinyl, indolyl, pyrimidinyl, imidazolyl, 1,2,4-triazolyl, tetrazolyl, etc.
  • heteroatom-containing alicyclic groups include without limitation pyrrolidino, morpholino, piperazino, piperidino, etc.
  • substituted as in “substituted hydrocarbyl,” “substituted alkyl,” “substituted aryl,” and the like, as alluded to in some of the aforementioned definitions, is meant that in the hydrocarbyl, alkyl, aryl, or other moiety, at least one hydrogen atom bound to a carbon (or other) atom is replaced with one or more non-hydrogen substituents.
  • substituents include, without limitation: functional groups referred to herein as "Fn,” such as halo, hydroxyl, sulfhydryl, C 1 -C 24 alkoxy, C 2 -C 24 alkenyloxy, C 2 -C 24 alkynyloxy, C 5 -C 24 aryloxy, C 6 -C 24 aralkyloxy, C 6 -C 24 alkaryloxy, acyl (including C 2 -C 24 alkylcarbonyl (-CO-alkyl) and C 6 -C 24 arylcarbonyl (-CO-aryl)), acyloxy (-O-acyl, including C 2 -C 24 alkylcarbonyloxy (-O-CO-alkyl) and C 6 -C 24 arylcarbonyloxy (-O-CO-aryl)), C 2 -C 24 alkoxycarbonyl (-(CO)-O-alkyl), C 6 -C 24 aryloxycarbonyl (--C
  • “functionalized” as in “functionalized hydrocarbyl,” “functionalized alkyl,” “functionalized olefin,” “functionalized cyclic olefin,” and the like, is meant that in the hydrocarbyl, alkyl, olefin, cyclic olefin, or other moiety, at least one hydrogen atom bound to a carbon (or other) atom is replaced with one or more functional groups such as those described hereinabove.
  • the term “functional group” is meant to include any functional species that is suitable for the uses described herein. In particular, as used herein, a functional group would necessarily possess the ability to react with or bond to corresponding functional groups on a substrate surface.
  • the aforementioned functional groups may, if a particular group permits, be further substituted with one or more additional functional groups or with one or more hydrocarbyl moieties such as those specifically enumerated above.
  • the above mentioned hydrocarbyl moieties may be further substituted with one or more functional groups or additional hydrocarbyl moieties such as those specifically mentioned above.
  • the above-mentioned hydrocarbyl moieties may be further substituted with one or more functional groups or additional hydrocarbyl moieties as noted above.
  • Optional or “optionally” means that the subsequently described circumstance may or may not occur, so that the description includes instances where the circumstance occurs and instances where it does not.
  • the phrase “optionally substituted” means that a non-hydrogen substituent may or may not be present on a given atom, and, thus, the description includes structures wherein a non-hydrogen substituent is present and structures wherein a non-hydrogen substituent is not present.
  • internal olefin means an olefin wherein each of the olefinic carbons (i.e., the carbons of the carbon-carbon double bond) is substituted by at least one non-hydrogen substituent.
  • the internal olefin may be di-substituted, tri-substituted, or tetra-substituted (e.g., R 1 'HC is CHR 2' ; R 3' R 4' C is CHR 5' ; R 6' R 7' C is CR 8' R 9' ; where R 1' , R 2' , R 3' , R 4' , R 5' , R 6' , R 7' , R 8' , and R 9' may be the same or different and are each independently optionally substituted hydrocarbyl, optionally substituted heteroatom-containing hydrocarbyl, or a functional group).
  • terminal olefin as used herein means an olefin wherein one of the olefinic carbons (i.e., the carbons of the carbon-carbon double bond) is substituted by at least one non-hydrogen substituent and the other olefinic carbon is unsubstituted.
  • the terminal olefin may be di-substituted or mono-substituted (e.g., CH 2 is CHR 10' or CH 2 is CR 11' R 12' ; where R 10' , R 11' , and R 12' may be the same or different and are each independently optionally substituted hydrocarbyl, optionally substituted heteroatom-containing hydrocarbyl, or a functional group).
  • reactant internal olefin means an internal olefin present in an olefin compound used in a cross metathesis reaction with another olefin compound to form a cross metathesis product.
  • the "reactant internal olefin” may be di-substituted, tri-substituted, or tetra-substituted.
  • the "reactant internal olefin” may have an E-configuration or a Z-configuration.
  • product internal olefin as used herein means an internal olefin present in a cross metathesis product formed by a cross metathesis reaction, wherein each of the olefinic carbons (i.e., the carbons of the carbon-carbon double bond) of the internal olefin is substituted by at least one non-hydrogen substituent.
  • the "product internal olefin” may be di-substituted, tri-substituted, or tetra-substituted.
  • the "product internal olefin” may have an E configuration or a Z-configuration.
  • hydroxyl as used herein, represents a group of formula "-OH”.
  • carbonyl as used herein, represents a group of formula "-C(O)-”.
  • ketone represents an organic compound having a carbonyl group linked to a carbon atom such as -C(O)R x wherein R x can be alkyl, aryl, cycloalkyl, cycloalkenyl, heterocycle as defined above.
  • esters represents an organic compound having a carbonyl group linked to a carbon atom such as -C(O)OR x wherein R x can be alkyl, aryl, cycloalkyl, cycloalkenyl, heterocycle as defined above.
  • amine as used herein, represents a group of formula "-NR x R y ",wherein R x and R y can be the same or independently H, alkyl, aryl, cycloalkyl, cycloalkenyl, heterocycle as defined above.
  • sulfonyl as used herein, represents a group of formula "-SO 2 - ".
  • sulfonate represents a group of the formula "-S(O) 2 -O-".
  • carboxylic acid as used herein, represents a group of formula "-C(O)OH".
  • nitro as used herein, represents a group of formula "-NO 2 ".
  • cyano as used herein, represents a group of formula "-CN”.
  • amide as used herein, represents a group of formula "-C(O)NR x R y ,” wherein R x and R y can be the same or independently H, alkyl, aryl, cycloalkyl, cycloalkenyl, heterocycle as defined above.
  • sulfonamide represents a group of formula "-S(O) 2 NR x R y " wherein R x and R y can be the same or independently H, alkyl, aryl, cycloalkyl, cycloalkenyl, heterocycle as defined above.
  • sulfoxide as used herein, represents a group of formula "-S(O)-”.
  • phosphonic acid as used herein, represents a group of formula "-P(O)(OH) 2 ".
  • phosphoric acid as used herein, represents a group of formula "-OP(O)(OH) 2 ".
  • sulphonic acid as used herein, represents a group of formula "-S(O) 2 OH”.
  • N represents a nitrogen atom
  • Functional groups may be protected in cases where the functional group interferes with the metathesis catalyst, and any of the protecting groups commonly used in the art may be employed. Acceptable protecting groups may be found, for example, in Greene et al., Protective Groups in Organic Synthesis, 3rd Ed. (New York: Wiley, 1999 ). Examples of protecting groups include acetals, cyclic acetals, boronate esters (boronates), cyclic boronate esters (cyclic boronates), carbonates, or the like. Examples of protecting groups include cyclic acetals or cyclic boronate esters.
  • the invention provides a compound of Formula (I):
  • the invention provides a catalyst represented by Formula (I) wherein:
  • the invention provides a catalyst represented by Formula (I) wherein:
  • the invention provides a catalyst represented by Formula (I) wherein:
  • the invention provides a catalyst represented by Formula (I) wherein:
  • the invention provides a catalyst represented by Formula (I) wherein: X is S; Y is S; Z is N; W is O; R 1 is hydrogen or optionally substituted C 1-8 alkyl;
  • the invention provides a catalyst represented by Formula (I) wherein: X is S; Y is S; Z is N; W is O; R 1 is hydrogen or optionally substituted C 1-8 alkyl; R 2 is hydrogen or optionally substituted C 1-8 alkyl; R 3 is hydrogen; R 4 is hydrogen; R 5 is hydrogen, optionally substituted C 1-8 alkyl or halogen; R 6 is hydrogen or optionally substituted C 1-8 alkyl; R 7 is hydrogen, optionally substituted C 1-8 alkyl or halogen; R 8 is hydrogen or optionally substituted C 1-8 alkyl; R 9 is hydrogen, optionally substituted C 1-8 alkyl or halogen; R 10 is hydrogen, optionally substituted C 1-8 alkyl or halogen; R 11 is hydrogen or optionally substituted C 1-8 alkyl; R 12 is hydrogen, optionally substituted C 1-8 alkyl or halogen; R 13 is hydrogen or optionally substituted C 1-8 alkyl; R 14 is hydrogen, optionally substituted C 1-8
  • the invention provides a catalyst represented by Formula (I) wherein: X is S; Y is S; Z is N; W is O; R 1 is hydrogen or optionally substituted C 1-8 alkyl;
  • the invention provides a catalyst represented by Formula (I) wherein: X is S; Y is S; Z is N; W is O; R 1 is hydrogen; R 2 is hydrogen; R 3 is hydrogen; R 4 is hydrogen; R 5 is hydrogen, halogen or optionally substituted C 1-8 alkyl; R 6 is hydrogen or optionally substituted C 1-8 alkyl; R 7 is hydrogen or optionally substituted C 1-8 alkyl;
  • the invention provides a catalyst represented by Formula (I) wherein: X is S; Y is S; Z is N; W is O; R 1 is optionally substituted C 1-8 alkyl; R 2 is optionally substituted C 1-8 alkyl; R 3 is hydrogen; R 4 is hydrogen; R 5 is halogen; R 6 is hydrogen; R 7 is halogen; R 8 is hydrogen; R 9 is halogen; R 10 is halogen; R 11 is hydrogen; R 12 is hydrogen or halogen; R 13 is hydrogen; R 14 is halogen; R 15 is halogen; R 16 is hydrogen; R 17 is hydrogen or together with R 18 forms an optionally substituted naphtyl or phenantryl ring; R 18 is halogen or together with R 17 forms an optionally substituted naphtyl or phenantryl ring; R 19 is optionally substituted C 1-8 alkyl; R 20 is hydrogen; R 21 is hydrogen; R 22 is hydrogen; R 23 is hydrogen; and R 24 is hydrogen.
  • R 5 is halogen
  • the invention provides a catalyst represented by Formula (I) wherein: X is S; Y is S; Z is N; W is O; R 1 is hydrogen; R 2 is hydrogen; R 3 is hydrogen;
  • the invention provides a catalyst represented by Formula (I) wherein: X is S; Y is S; Z is N; W is O; R 1 is methyl; R 2 is methyl; R 3 is hydrogen; R 4 is hydrogen; R 5 is F; R 6 is hydrogen; R 7 is hydrogen or F; R 8 is hydrogen; R 9 is F; R 10 is F; R 11 is hydrogen; R 12 is hydrogen or F; R 13 is hydrogen; R 14 is F; R 15 is Cl; R 16 is hydrogen; R 17 is hydrogen or together with R 18 forms naphtyl or phenanthryl; R 18 is hydrogen, Cl, or together with R 17 forms naphtyl or phenanthryl; R 19 is i-Pr; R 20 is hydrogen; R 21 is hydrogen; R 22 is hydrogen; R 23 is hydrogen; and R 24 is hydrogen.
  • Formula (I) wherein: X is S; Y is S; Z is N; W is O; R 1 is methyl; R 2 is methyl; R 3 is hydrogen; R 4 is hydrogen; R 5 is F
  • the invention provides a catalyst represented by Formula (I) wherein: X is S; Y is S; Z is N; W is O; R 1 is Me; R 2 is Me; R 3 is hydrogen; R 4 is hydrogen; R 5 is Me or F; R 6 is hydrogen; R 7 is hydrogen or F; R 8 is hydrogen; R 9 is hydrogen or F; R 10 is Me or F; R 11 is hydrogen; R 12 is hydrogen or F; R 13 is hydrogen; R 14 is hydrogen or F; R 15 is hydrogen or Cl; R 16 is hydrogen; R 17 is hydrogen or together with R 18 forms naphthyl or phenantryl; R 18 is Cl, phenyl or together with R 17 forms naphthyl or phenantryl; R 19 is i-Pr; R 20 is hydrogen; R 21 is hydrogen; R 22 is hydrogen; R 23 is hydrogen; and R 24 is hydrogen.
  • Formula (I) wherein: X is S; Y is S; Z is N; W is O; R 1 is Me; R 2 is Me; R 3 is hydrogen; R 4 is
  • the invention provides a catalyst represented by Formula (I) wherein: X is S; Y is S; Z is N; W is O; R 1 is hydrogen; R 2 is hydrogen; R 3 is hydrogen; R 4 is hydrogen; R 5 is Me, F or i-Pr; R 6 is hydrogen or t-Bu; R 7 is hydrogen or Me; R 8 is hydrogen or t-Bu; R 9 is hydrogen, Me, t-Bu, F or i-Pr; R 10 is hydrogen, Me, F or i-Pr; R 11 is hydrogen or t-Bu; R 12 is hydrogen or Me; R 13 is hydrogen or t-Bu; R 14 is hydrogen, Me, F or i-Pr; R 15 is hydrogen, methyl or Cl, or together with R 16 forms 2-phenyl-naphthyl or phenanthryl; R 16 is hydrogen, or together with R 15 forms 2-phenyl-naphthyl or phenanthryl; R 17 is hydrogen or together with R 18 forms 2-phenyl-n
  • the invention provides a compound wherein the moiety of Formula (I) is
  • the invention provides a compound wherein the moiety of Formula (I) is
  • the invention provides a compound wherein the moiety of Formula (I) is
  • the invention provides a compound of Formula (I) is selected from:
  • a compound of Formula (I) is an olefin metathesis catalyst. In one embodiment, a compound of Formula (I) is a Z-selective olefin metathesis catalyst.
  • a compound of Formula (I) is an olefin metathesis catalyst. In one embodiment, a compound of Formula (I) is an E-selective olefin metathesis catalyst.
  • an olefin reactant comprises a reactant internal olefin, wherein the reactant internal olefin is in a Z-configuration.
  • an olefin reactant comprises a reactant internal olefin, wherein the reactant internal olefin is di-substituted and is in a Z-configuration.
  • an olefin reactant comprising a reactant internal olefin is represented by the structure of Formula (1): wherein,
  • first internal olefin reactant there is a first internal olefin reactant and a second internal olefin reactant, where the first internal olefin reactant and the second internal olefin reactant may be the same or different, wherein the first internal olefin reactant and the second internal olefin reactant are each in a Z-configuration.
  • first internal olefin reactant and a second internal olefin reactant there is a first internal olefin reactant and a second internal olefin reactant, where the first internal olefin reactant and the second internal olefin reactant may be the same or different, wherein the first olefin reactant and the second olefin reactant each comprise a reactant internal olefin.
  • first internal olefin reactant and a second internal olefin reactant where the first internal olefin reactant and the second internal olefin reactant may be the same or different, wherein the first internal olefin reactant and the second internal olefin reactant each comprise a reactant internal olefin, wherein the reactant internal olefin is di-substituted and in a Z-configuration.
  • first internal olefin reactant there is a first internal olefin reactant and a second internal olefin reactant, where the first internal olefin reactant is of Formula (1) and the second internal olefin reactant is of Formula (1), wherein the first internal olefin reactant and the second internal olefin reactant may be the same or different.
  • an olefin reactant comprises a reactant internal olefin, wherein the reactant internal olefin is in an E-configuration.
  • an olefin reactant comprises a reactant internal olefin, wherein the reactant internal olefin is di-substituted and is in an E-configuration.
  • an olefin reactant comprising a reactant internal olefin is represented by the structure of Formula (2): wherein
  • first internal olefin reactant there is a first internal olefin reactant and a second internal olefin reactant, where the first internal olefin reactant and the second internal olefin reactant may be the same or different, wherein the first internal olefin reactant and the second internal olefin reactant are each in an E-configuration.
  • first internal olefin reactant and a second internal olefin reactant where the first internal olefin reactant and the second internal olefin reactant may be the same or different, wherein the first internal olefin reactant and the second internal olefin reactant each comprise a reactant internal olefin, wherein the reactant internal olefin is di-substituted and is in an E-configuration.
  • first internal olefin reactant there is a first internal olefin reactant and a second internal olefin reactant, where the first internal olefin reactant is of Formula (2) and the second internal olefin reactant is of Formula (2), wherein the first internal olefin reactant and the second internal olefin reactant may be the same or different.
  • the second olefin reactant comprising a terminal olefin may be represented by the structure of Formula (3): wherein U ⁇ is selected from the group comprising nil, CH 2 , O, or S and T ⁇ is selected from the group consisting of hydrogen, hydrocarbyl (e.g., C 1 -C 20 alkyl, C 5 -C 20 aryl, C 5 -C 30 aralkyl, or C 5 -C 30 alkaryl), substituted hydrocarbyl (e.g., substituted C 1 -C 20 alkyl, C 5 -C 20 aryl, C 5 -C 30 aralkyl, or C 5 -C 30 alkaryl), heteroatom-containing hydrocarbyl (e.g., C 1 -C 20 heteroalkyl, C 5 -C 20 heteroaryl, heteroatom-containing C 5 -C 30 aralkyl, or heteroatom-containing C 5 -C 30 alkaryl), and substituted heteroatom-containing hydrocarbyl
  • first internal olefin reactant there is a first internal olefin reactant and a second terminal olefin reactant, wherein the first internal olefin reactant is in an E-configuration.
  • first internal olefin reactant there is a first internal olefin reactant and a second terminal olefin reactant, wherein the first internal olefin reactant is in a Z -configuration.
  • first internal olefin reactant there is a first internal olefin reactant and a second terminal olefin reactant, where the first internal olefin reactant is of Formula (1) and the second terminal olefin reactant is of Formula (3).
  • first internal olefin reactant there is a first internal olefin reactant and a second terminal olefin reactant, where the first internal olefin reactant is of Formula (2) and the second terminal olefin reactant is of Formula (3).
  • the olefin product is at least one cross metathesis product, wherein the at least one cross metathesis product is in a Z -configuration.
  • the olefin product is at least one cross metathesis product, wherein the at least one cross metathesis product is di-substituted and is in a Z -configuration.
  • an at least one cross metathesis product comprises a product internal olefin, wherein the product internal olefin is in a Z -configuration.
  • an at least one cross metathesis product comprises a product internal olefin, wherein the product internal olefin is di-substituted and is in a Z -configuration.
  • the olefin product is at least one cross metathesis product, wherein the at least one cross metathesis product is in an E -configuration.
  • the olefin product is at least one cross metathesis product, wherein the at least one cross metathesis product is di-substituted and is in an E -configuration.
  • an at least one cross metathesis product comprises a product internal olefin, wherein the product internal olefin is in an E -configuration.
  • an at least one cross metathesis product comprises a product internal olefin, wherein the product internal olefin is di-substituted and is in an E -configuration.
  • the invention provides a method that produces a compound (i.e., a product, olefin product; e.g., cross metathesis product) having a carbon-carbon double bond (e.g., a product internal olefin) in a Z : E ratio greater than about 1:1, greater than about 2:1, greater than about 3: 1, greater than about 4: 1, greater than about 5:1, greater than about 6:1, greater than about 7:1, greater than about 8:1, greater than about 9:1, greater than about 95:5, greater than about 96:4, greater than about 97:3, greater than about 98:2, or in some cases, greater than about 99: 1.
  • about 100% of the carbon-carbon double bond produced in the metathesis reaction may have a Z configuration.
  • the Z or cis selectivity may also be expressed as a percentage of product formed (e.g., cross metathesis product).
  • the product e.g., cross metathesis product
  • the product may be greater than about 50% Z , greater than about 60% Z , greater than about 70% Z, greater than about 80% Z , greater than about 90% Z , greater than about 95% Z , greater than about 96% Z , greater than about 97% Z , greater than about 98% Z , greater than about 99% Z , or in some cases greater than about 99.5% Z .
  • an at least one cross metathesis product comprising a product internal olefin is represented by the structure of Formula (4): wherein,
  • the invention provides a method that produces a compound (i.e., a product, olefin product; e.g., cross metathesis product) having a carbon-carbon double bond (e.g., a product internal olefin) in an E:Z ratio greater than about 1:1, greater than about 2:1, greater than about 3:1, greater than about 4:1, greater than about 5:1, greater than about 6:1, greater than about 7:1, greater than about 8:1, greater than about 9:1, greater than about 95:5, greater than about 96:4, greater than about 97:3, greater than about 98:2, or in some cases, greater than about 99: 1.
  • about 100% of the carbon-carbon double bond produced in the metathesis reaction may have an E configuration.
  • the E or trans selectivity may also be expressed as a percentage of product formed (e.g., cross metathesis product).
  • the product e.g., cross metathesis product
  • the product may be greater than about 50% E , greater than about 60% E , greater than about 70% E , greater than about 80% E , greater than about 90% E , greater than about 95% E , greater than about 96% E , greater than about 97% E , greater than about 98% E , greater than about 99% E , or in some cases greater than about 99.5% E .
  • an at least one cross metathesis product comprising a product internal olefin, wherein the product internal olefin is in the E -configuration
  • a cross metathesis product comprising a product internal olefin, wherein the product internal olefin is in the E -configuration
  • D 19 and D 21 are identical or are independently selected from nil, CH 2 , O, or S
  • E 19 and E 21 are identical or are independently selected from hydrogen, hydrocarbyl (e.g., C 1 -C 20 alkyl, C 5 -C 20 aryl, C 5 -C 30 aralkyl, or C 5 -C 30 alkaryl), substituted hydrocarbyl (e.g., substituted C 1 -C 20 alkyl, C 5 -C 20 aryl, C 5 -C 30 aralkyl, or C 5 -C 30 alkaryl), heteroatom-containing hydrocarbyl (e.g., C 1 -C 20 heteroalkyl, C
  • GC Methods Volatile products were analyzed using an Agilent 6850 gas chromatography (GC) instrument with a flame ionization detector (FID). The following conditions and equipment were used:
  • C765 was synthesized according to the procedure described in US 2014/0371454 . C765 was isolated as red/brown crystals in 97.1% yield.
  • N , N '-bis(2,6-difluorophenyl)formimidamide (4.00 g, 14.9 mmol)
  • 3-bromo-2-methylpropene (1.65 mL, 16.4 mmol
  • chlorobenzene 120 mL
  • the reaction was heated to 125 °C for 24 h. After cooling the resulting precipitate was isolated by filtration and washed with diethyl ether (2 x 20 mL).
  • the crude product was then partitioned between dichloromethane and an aqueous sodium tetrafluoroborate solution (100 mL, 1:1, 2.0 g NaBF 4 /50 mL).
  • N , N' -bis(2,4,6-trifluorophenyl)formimidamide 0.511 g, 1.68 mmol
  • 3-bromo-2-methylpropene 0.200 mL, 1.97 mmol
  • ortho -dichlorobenzene 4 mL
  • the reaction was heated to 120 °C for 60 h. After cooling to 0 °C the resulting precipitate was isolated by filtration and washed with hexanes (3 x 15 mL).
  • 1,3-bis(2,4,6-difluorophenyl)-4,4-dimethyl-4,5-dihydro-1H-imidazol-3-ium bromide (0.300 g, 0.683 mmol
  • sodium tert -butoxide (0.0656 g, 0.683 mmol)
  • C823 0.281 g, 0.342 mmol
  • Table 2 summarizes a series of reactions where C765 (0.5 mol %) was exposed to various ratios of cis and trans- 5C14. While good stereoretention is attainable when isomerically pure starting material is used (entries 1 and 5), product distributions from reactions with mixtures of cis and trans -5C14 were complicated by the difference in reactivity of cis and trans stereoisomers.
  • Table 4 summarizes a series of reactions where C849z (500 ppm) was exposed to various ratios of cis and trans- 5C14 . Unlike C765, C849z afforded product distributions that approach theoretical, when the trans- 5-tetradecene is considered an unreactive stereoisomer.
  • Table 6 summarizes a series of reactions where C849z (1000 ppm) was exposed to various ratios of cis and trans -methyl-9-octadecenoate. Reactions with 80 or 100% cis -methyl-9-octadecenoate (entries 1 and 2) afforded near theoretical product distributions after 4 hours with excellent stereoretention. Reactions conducted with an increased trans -methyl-9-octadecenoate content (entries 3-5) afforded very little reactivity although products maintained high fidelity.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EP24186768.8A 2015-12-10 2016-12-09 Olefinmetathesekatalysatoren Pending EP4431180A3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562265575P 2015-12-10 2015-12-10
US201662377337P 2016-08-19 2016-08-19
PCT/US2016/065844 WO2017100585A1 (en) 2015-12-10 2016-12-09 Olefin metathesis catalysts
EP16873924.1A EP3386936B1 (de) 2015-12-10 2016-12-09 Olefinmetathesekatalysatoren

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP16873924.1A Division EP3386936B1 (de) 2015-12-10 2016-12-09 Olefinmetathesekatalysatoren

Publications (2)

Publication Number Publication Date
EP4431180A2 true EP4431180A2 (de) 2024-09-18
EP4431180A3 EP4431180A3 (de) 2024-11-20

Family

ID=59013592

Family Applications (2)

Application Number Title Priority Date Filing Date
EP16873924.1A Active EP3386936B1 (de) 2015-12-10 2016-12-09 Olefinmetathesekatalysatoren
EP24186768.8A Pending EP4431180A3 (de) 2015-12-10 2016-12-09 Olefinmetathesekatalysatoren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP16873924.1A Active EP3386936B1 (de) 2015-12-10 2016-12-09 Olefinmetathesekatalysatoren

Country Status (11)

Country Link
US (2) US10857530B2 (de)
EP (2) EP3386936B1 (de)
JP (3) JP6882295B2 (de)
KR (1) KR20180116238A (de)
CN (1) CN108368001B (de)
CA (1) CA3006976A1 (de)
HU (1) HUE067920T2 (de)
IL (1) IL259758A (de)
MX (1) MX2018006987A (de)
PL (1) PL3386936T3 (de)
WO (1) WO2017100585A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180116238A (ko) * 2015-12-10 2018-10-24 우미코레 아게 운트 코 카게 올레핀 복분해 촉매
ES2937742T3 (es) 2016-08-24 2023-03-30 Umicore Ag & Co Kg Síntesis y caracterización de catalizadores de metátesis
PL3865495T3 (pl) 2016-11-09 2025-01-27 Verbio Vereinigte Bioenergie Ag Kompleksy rutenu przydatne do katalizowania reakcji metatezy
BR112020016342A2 (pt) * 2018-02-13 2020-12-15 Umicore Ag & Co. Kg Reações de derivados de olefina na presença de catalisadores de metátese
CN112119055A (zh) * 2018-05-15 2020-12-22 加利福尼亚技术学院 通过立体保留性复分解全合成前列腺素j天然产物
CN110818564A (zh) * 2019-11-21 2020-02-21 石河子大学 一种利用不饱和脂肪酸酯制备高碳二元酸酯的方法
MX2022015178A (es) 2020-06-01 2023-03-01 Provivi Inc Sintesis de feromonas derivadas a traves de metatesis olefinica selectiva en z.
CN114213401B (zh) * 2021-12-15 2023-07-18 华南理工大学 氮杂卡宾类化合物及其制备方法
PL439977A1 (pl) * 2021-12-23 2023-06-26 Apeiron Synthesis Spółka Akcyjna Nowe sterycznie aktywowane chelatujące kompleksy rutenu, sposób ich otrzymywania oraz ich zastosowanie w reakcjach metatezy olefin
PL440147A1 (pl) * 2022-01-17 2023-07-24 Uniwersytet Warszawski Nowe stereoretentywne kompleksy rutenu, sposób ich otrzymywania, związki pośrednie stosowane w tym sposobie oraz zastosowanie nowych stereoretentywnych kompleksów rutenu w reakcjach metatezy olefin
CN114634436B (zh) * 2022-04-08 2022-12-02 安徽泽升科技有限公司 一种含钌催化剂及其制备方法与用途
EP4686722A1 (de) 2024-07-29 2026-02-04 Umicore AG & Co. KG Metallorganische verbindungen
WO2026027552A2 (en) 2024-07-29 2026-02-05 Umicore Ag & Co. Kg Metal organic compounds

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009094201A2 (en) 2008-01-25 2009-07-30 Trustees Of Boston College Catalysts for metathesis reactons including enantioselective olefin metathesis, and related methods
WO2012097379A2 (en) 2011-01-14 2012-07-19 California Institute Of Technology Z-selective olefin metathesis catalysts and their synthetic procedure
WO2014093687A1 (en) 2012-12-12 2014-06-19 California Institute Of Technology Z-selective metathesis catalysts
US20140371454A1 (en) 2013-06-12 2014-12-18 Trustees Of Boston College Catalysts for efficient z-selective metathesis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696597B2 (en) * 1998-09-01 2004-02-24 Tilliechem, Inc. Metathesis syntheses of pheromones or their components
EP1230207B1 (de) * 1999-11-18 2005-06-22 Richard L. Pederson Methathesesynthese von pheromonen oder ihrer bestandteile
EP1379485A4 (de) 2001-03-30 2005-08-31 California Inst Of Techn Selektive kreuzmetathese von cycloolefinen unter ringöffnung
MXPA06011302A (es) 2004-03-29 2007-01-16 Materia Inc Catalizadores de metatesis de olefinas de alta actividad, latentes que contienen un ligando de carbeno n-heterociclico.
KR20080103961A (ko) * 2005-12-16 2008-11-28 마터리아 인코포레이티드 유기금속 루테늄 착물, 및 사치환 및 기타 입체장애된올레핀의 제조를 위한 관련 방법
WO2008008440A2 (en) * 2006-07-12 2008-01-17 Elevance Renewable Sciences, Inc. Ring opening cross-metathesis reaction of cyclic olefins with seed oils and the like
FR2909382B1 (fr) 2006-11-30 2009-01-23 Enscr Complexes catalytiques a base de ruthenium et utilisation de tels complexes pour la metathese d'olefines
EP2428269A1 (de) 2010-09-08 2012-03-14 Bergen Teknologioverføring AS Neue Olefin-Metathesen-Katalysatoren
JP6092379B2 (ja) * 2012-06-29 2017-03-08 アペイロン シンセシス エス アー 金属錯体、その適用、及びメタセシス反応の実施方法
PL400162A1 (pl) * 2012-07-27 2014-02-03 Apeiron Synthesis Spólka Z Ograniczona Odpowiedzialnoscia Nowe kompleksy rutenu, ich zastosowanie w reakcjach metatezy oraz sposób prowadzenia reakcji metatezy
US20160101414A1 (en) * 2013-05-15 2016-04-14 California Institute Of Technology Highly z-selective and enantioselective ring opening/cross metathesis catalyzed by a resolved stereogenic-at-ru complex
KR20180116238A (ko) * 2015-12-10 2018-10-24 우미코레 아게 운트 코 카게 올레핀 복분해 촉매
PL3865495T3 (pl) 2016-11-09 2025-01-27 Verbio Vereinigte Bioenergie Ag Kompleksy rutenu przydatne do katalizowania reakcji metatezy

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009094201A2 (en) 2008-01-25 2009-07-30 Trustees Of Boston College Catalysts for metathesis reactons including enantioselective olefin metathesis, and related methods
WO2012097379A2 (en) 2011-01-14 2012-07-19 California Institute Of Technology Z-selective olefin metathesis catalysts and their synthetic procedure
WO2014093687A1 (en) 2012-12-12 2014-06-19 California Institute Of Technology Z-selective metathesis catalysts
US20140371454A1 (en) 2013-06-12 2014-12-18 Trustees Of Boston College Catalysts for efficient z-selective metathesis
WO2014201300A1 (en) 2013-06-12 2014-12-18 Trustees Of Boston College Catalysts for efficient z-selective metathesis

Non-Patent Citations (17)

* Cited by examiner, † Cited by third party
Title
BINDER, J.B.RAINES, R.T., CURR. OPIN. CHEM. BIOL., vol. 12, 2008, pages 767
FLOOK, M. M.JIANG, A. J.SCHROCK, R. R.MULLER, P.HOVEYDA, A. H, J. AM. CHEM. SOC., vol. 131, 2009, pages 16630
FURSTNER, A., ANGEW. CHEM., INT. ED., vol. 39, 2000, pages 3013
GREENE ET AL.: "Protective Groups in Organic Synthesis", 1999, WILEY
GRUBBS, R. H.: "Handbook of Metathesis", 2003, WILEY-VCH
KEITZ, B. K.ENDO, K.PATEL, P. R.HERBERT, M. B.GRUBBS, R. H., J. AM. CHEM. SOC., vol. 134, 2011, pages 9686
KHAN, R. K. M.TORKER, S.HOVEYDA, A. H., J. AM. CHEM. SOC., vol. 135, 2013, pages 10258
KOH, M. J.KHAN, K.M.TORKER, S.YU, M.MIKUS, M.S.HOVEYDA, A.M, NATURE, vol. 517, 2015, pages 181
LEITGEB, A.WAPPEL, J.SLUGOVC, C, POLYMER, vol. 51, 2010, pages 2927
LIU, XBASU, A., J. ORGANOMET. CHEM., vol. 691, 2006, pages 5148
MARINESCU, S. C.SCHROCK, R. R.MULLER, P.TAKASE, M. K.HOVEYDA, A. H, ORGANOMETALLICS, vol. 30, 2011, pages 1780
MEEK, S. J.O'BRIEN, R. V.LLAVERIA, J.SCHROCK, R. R.HOVEYDA, A. H., NATURE, vol. 471, 2011, pages 461
SAMOJLOWICZ, C.BIENIEK, M.GRELA, K., CHEM. REV., vol. 109, 2009, pages 3708
SCHROCK, R. R., CHEM. REV., vol. 102, 2002, pages 145
SCHROCK, R. R.HOVEYDA, A. H., ANGEW. CHEM., INT. ED, vol. 42, 2003, pages 4592
SUTTHASUPA, S.SHIOTSUKI, M.SANDA, F, POLYM. J., vol. 42, 2010, pages 905
TRNKA, T. M.GRUBBS, R. H, ACC. CHEM. RES., vol. 34, 2001, pages 18

Also Published As

Publication number Publication date
CA3006976A1 (en) 2017-06-15
EP4431180A3 (de) 2024-11-20
US20180361371A1 (en) 2018-12-20
JP2018538301A (ja) 2018-12-27
WO2017100585A1 (en) 2017-06-15
JP6882295B2 (ja) 2021-06-02
PL3386936T3 (pl) 2024-10-07
JP2021080283A (ja) 2021-05-27
JP2023054086A (ja) 2023-04-13
CN108368001B (zh) 2021-07-23
KR20180116238A (ko) 2018-10-24
EP3386936A4 (de) 2019-08-07
EP3386936B1 (de) 2024-07-10
IL259758A (en) 2018-07-31
MX2018006987A (es) 2019-05-16
US10857530B2 (en) 2020-12-08
US20210053043A1 (en) 2021-02-25
CN108368001A (zh) 2018-08-03
EP3386936A1 (de) 2018-10-17
HUE067920T2 (hu) 2024-11-28

Similar Documents

Publication Publication Date Title
EP3386936B1 (de) Olefinmetathesekatalysatoren
KR101835170B1 (ko) Z-선택적 올레핀 복분해 촉매 및 이들의 합성 절차
JP4676617B2 (ja) イソプレゴールの製造方法
US20170022232A1 (en) Method for in-situ formation of metathesis catalysts
EP3496855B1 (de) Metathesekatalysatoren
EP2921229A1 (de) Aluminiumkatalysator
WO2020109217A2 (en) Metal organic compounds
JP2013542219A (ja) 含窒素複素環式カルベン錯体、その製造及びその使用方法
US9676676B2 (en) Selective olefin metathesis with cyclometalated ruthenium complexes
US20160200746A1 (en) Titanium (iv) compounds and methods of forming heterocyclic compounds using same
CN112119055A (zh) 通过立体保留性复分解全合成前列腺素j天然产物
CN118221589A (zh) 一种手性1,3-戊二烯基-5-(2h)-吲唑化合物的合成方法
Reich et al. The first organoselenium ate complex
Bibal et al. A selective synthesis of hydroxyborate anions as novel anchors for zirconocene catalysts
Widaman et al. New five-coordinate Ru (II) phosphoramidite complexes and their catalytic activity in propargylic amination reactions
JP2021513572A (ja) メタセシス触媒の存在下におけるオレフィン誘導体の反応
CN114106057B (zh) Ru亚烷基络合物的合成与表征
CN104437642B (zh) 一种用于烯烃复分解反应的催化剂及其制备方法
US20240150384A1 (en) Long shelf life stable organoruthenium complexes as (pre)catalysts for olefin metathesis
RU2355698C2 (ru) Способ получения 9-хлор-10,11-диалкил-9-алюминабицикло[6.3.0]ундека-1(8),10-диенов
RU2383538C1 (ru) СПОСОБ ПОЛУЧЕНИЯ 1,2,3,4,5,6,10,11,12,13,14,15,15a,15b-ТЕТРАДЕКАГИДРОДИЦИКЛОНОНА [b, d]СЕЛЕНОФЕНА
US20050119416A1 (en) Arene-ruthenium complexes immobilized on polymers, catalysts consisting of the complexes, and processes for organic syntheses with the same
JP6938511B2 (ja) 新規な安定性シリル化試薬
RU2136688C1 (ru) Способ совместного получения моно[циклоалкил]димагнийбромид[60]фуллеренов и бис[циклоалкил]тетрамагнийбромид[60]фуллеренов
JP5981747B2 (ja) アザディールス−アルダー反応用触媒、それを用いたテトラヒドロピリジン化合物の製造方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AC Divisional application: reference to earlier application

Ref document number: 3386936

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: B01J0031220000

Ipc: C07C0006060000

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RIC1 Information provided on ipc code assigned before grant

Ipc: B01J 31/22 20060101ALI20241011BHEP

Ipc: C07C 6/06 20060101AFI20241011BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20250520

RIN1 Information on inventor provided before grant (corrected)

Inventor name: PEDERSON, RICHARD L.

Inventor name: GRUBBS, ROBERT H.

Inventor name: AHMED, TONIA S.

Inventor name: MONTGOMERY, PATRIC T.

Inventor name: JOHNS, ADAM

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20250717